Interestingly, the use of an alternative start codon in human preproinsulin mRNA can lead to the translation of a nonconventional insulin product and the generation of neoantigenic peptides thereof, which are targets of T cell-mediated autoimmunity in type 1 diabetes [44]. The gene discussed is INS; the disease is type 1 diabetes mellitus.